Journal of Pharmaceutical Investigation

The Korean Society of Pharmaceutical Sciences and Technology (한국약제학회)
권호 표지
DOI QR코드

DOI QR Code

Buccal Delivery of [D-Ala2, D-Leu5]Enkephalin Incorporated in Mucoadhesive Poly(acrylic acid) Hydrogels

  • Published : 2005.10.20
Download PDF
⟨ Previous Next ⟩

Abstract

The objectives of the current work is to understand the factors impacting the formulation and performance of a Carbopol mucoadhesive buccal delvery system for a model peptide drug, $[D-Ala{^2},\;D-Leu{^5}]$enkephalin (DADLE, Mw=569.7) with comparable chemical and enzymatic stability. Specifically, in vitro buccal DADLE delivery from the cross-linked poly(acrylic acid) (PAA) hydrogel system was characterized. In addition, the influences of several penetration enhancers on the ex vivo buccal absorption of DADLE were also studied. In this study, the PAA hydrogels generally swell to 100% of their original weight in the phosphate pH 7.4 buffer. The water penetration into the PAA hydrogel occurred based on a zero-order kinetics for the first 60 min and steadily decreased afterwards. From the release study, it can be seen that the initial DADLE release was so rapid and the rate of release of DADLE decreased as the time elapsed. The porcine buccal tissue was found to be permeable to DADLE with a flux value of $0.07%/cm{^2}/hr({\pm}0.01\;SD)$. From the ex vivo diffusion study, it was found that sodium taurodihydrofusidate showed a greater degree of enhancement compared to the phospholipids with an Enhancement Ratio (ER) of 8.7 compared to 2.7 and 1.9 for didecanoylphosphatidylcholine and lysophosphatidylcholine, respectively. The work encompassed within this paper has demonstrated the feasibility of using the PAA hydrogel delivery system with its good mucoadhesive properties for the buccal delivery of peptides.

Keywords

References

  1. J.D. Smart, I.W. Kellaway and H.E.C. Worthington, An in vitro investigation of muco-adhesive materials for use in controlled drug delivery, J. Pharm. Pharmacal., 36, 295-299 (1984) https://doi.org/10.1111/j.2042-7158.1984.tb04377.x
  2. V.H.L. Lee, Peptide and protein drug delivery: opportunities and challenges, Pharm. Int. Trends Rev., 5, 208-212 (1986)
  3. T. Nagai and Y. Machida, Buccal delivery systems using hydrogels, Adv. Drug Del. Rev., 11, 179-191 (1993) https://doi.org/10.1016/0169-409X(93)90032-Y
  4. J. Lee and I.W. Kellaway, Buccal permeation of [$D-Ala^2, D-Leu^5$]enkephalin from liquid crystalline phases of glyceryl monooleate, Int. J. Pharm., 195, 35-38 (2000) https://doi.org/10.1016/S0378-5173(99)00357-9
  5. J.H. Kou, D. Fleisher and G.L. Amidon, Modelling drug release from dynamically swelling poly(hydroxyethylmethacrylate-co-methacrylic acid) hydrogels, J. Cotrol. Rel., 12, 241-250 (1990) https://doi.org/10.1016/0168-3659(90)90105-3
  6. P.L. Ritger and N.A. Peppas, A simple equation for description of solute increase I. Fickian and non-Fickian release from nonswelling devices in the form of slabs, spheres, cylinders or discs, J. Control. Rel., 5, 23-36 (1987) https://doi.org/10.1016/0168-3659(87)90034-4
  7. J.P. Longenecker, A.C. Moses, J.S. Flier, R.D. Silver, M.C. Carey and E.J. Dubovi, Effects of sodium taurodihydrofusidate on nasal absorption of insulin in sheep, J. Pharm. Sci., 76, 351-355 (1987) https://doi.org/10.1002/jps.2600760502
  8. B.J. Aungst and N.J. Rogers, Comparison of the effects of various transmucosal absorption promoters on buccal insulin delivery, Int. J. Pharm., 53, 227-235 (1989) https://doi.org/10.1016/0378-5173(89)90316-5
  9. M.J. Deurloo, W.A..J.J. Hermens, S.G. Romeyn, J.C. Verhoef and F.W.H.M. Merkus, Absorption enhancement of intranasally administered insulin by sodium taurodihydrofusidate (STDHF) in rabbits and rats , Pharm. Res., 6, 853-856 (1989) https://doi.org/10.1023/A:1015904404442
  10. P.A. Baldwin, C.K. Klingbeil, C.J. Grimm and J.P. Longenecker The effect of sodium tauro-24 , 25-dihydrofusidate on the nasal absorption of human growth hormone in three animal modeIs, Pharm. Res., 7, 547-552 (1990) https://doi.org/10.1023/A:1015885204249
  11. T. Kissel, J.Drewe, S. Bantle, A. Rummelt and C. Beglinger, Tolerability and absorption enhancement of intranasally administered octreotide by sodium taurodihydrofusidate in healthy subject, Pharm. Res., 9, 52-57 (1992) https://doi.org/10.1023/A:1018927710280